格隆汇1月22日｜雅培公布2024年第四季度业绩，营收同比增长7.2%至109.7亿美元，但低于分析师平均预期的110.1亿美元；经调整后每股收益为1.34美元，符合预期。医疗器械部门的销售额为50.52亿美元，同比增长13.7%。

该公司预计，第一季度调整后每股收益将介乎1.05至1.09美元，低于分析师平均预期的1.11美元；2025年调整后每股收益将介乎5.05至5.25美元，分析师的平均预期为5.16美元。

海量资讯、精准解读，尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.